These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17721921)

  • 1. ADH-1 suppresses N-cadherin-dependent pancreatic cancer progression.
    Shintani Y; Fukumoto Y; Chaika N; Grandgenett PM; Hollingsworth MA; Wheelock MJ; Johnson KR
    Int J Cancer; 2008 Jan; 122(1):71-7. PubMed ID: 17721921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cadherin-1 and cadherin-3 cooperation determines the aggressiveness of pancreatic ductal adenocarcinoma.
    Siret C; Dobric A; Martirosyan A; Terciolo C; Germain S; Bonier R; Dirami T; Dusetti N; Tomasini R; Rubis M; Garcia S; Iovanna J; Lombardo D; Rigot V; André F
    Br J Cancer; 2018 Feb; 118(4):546-557. PubMed ID: 29161242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telmisartan anti-cancer activities mechanism through targeting N-cadherin by mimicking ADH-1 function.
    Khorsand M; Khajeh S; Eslami M; Nezafat N; Ghasemi Y; Razban V; Mostafavi-Pour Z
    J Cell Mol Med; 2022 Apr; 26(8):2392-2403. PubMed ID: 35224849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic targeting of N-cadherin is an effective treatment for multiple myeloma.
    Mrozik KM; Cheong CM; Hewett D; Chow AW; Blaschuk OW; Zannettino AC; Vandyke K
    Br J Haematol; 2015 Nov; 171(3):387-99. PubMed ID: 26194766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-cadherin inhibitor creates a microenvironment that protect TILs from immune checkpoints and Treg cells.
    Sun Y; Jing J; Xu H; Xu L; Hu H; Tang C; Liu S; Wei Q; Duan R; Guo J; Yang L
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33692219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of E-cadherin gene expression by collagen type I and type III in pancreatic cancer cell lines.
    Menke A; Philippi C; Vogelmann R; Seidel B; Lutz MP; Adler G; Wedlich D
    Cancer Res; 2001 Apr; 61(8):3508-17. PubMed ID: 11309315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VE-cadherin RGD motifs promote metastasis and constitute a potential therapeutic target in melanoma and breast cancers.
    Bartolomé RA; Torres S; Isern de Val S; Escudero-Paniagua B; Calviño E; Teixidó J; Casal JI
    Oncotarget; 2017 Jan; 8(1):215-227. PubMed ID: 27966446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reciprocal loop of hypoxia-inducible factor-1α (HIF-1α) and metastasis-associated protein 2 (MTA2) contributes to the progression of pancreatic carcinoma by suppressing E-cadherin transcription.
    Zhu S; Deng S; He C; Liu M; Chen H; Zeng Z; Zhong J; Ye Z; Deng S; Wu H; Wang C; Zhao G
    J Pathol; 2018 Jul; 245(3):349-360. PubMed ID: 29708271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-Based Virtual Screening Allows the Identification of Efficient Modulators of E-Cadherin-Mediated Cell-Cell Adhesion.
    Dalle Vedove A; Falchi F; Donini S; Dobric A; Germain S; Di Martino GP; Prosdocimi T; Vettraino C; Torretta A; Cavalli A; Rigot V; André F; Parisini E
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31373305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel peptide mimetic small molecules of the HAV motif in N-cadherin inhibit N-cadherin-mediated neurite outgrowth and cell adhesion.
    Burden-Gulley SM; Gates TJ; Craig SE; Lou SF; Oblander SA; Howell S; Gupta M; Brady-Kalnay SM
    Peptides; 2009 Dec; 30(12):2380-7. PubMed ID: 19765627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell adhesion and cytolysis of pancreatic cancer cells: a role for E-cadherin in immunotherapy?
    French JJ; Cresswell J; Wong WK; Seymour K; Charnley RM; Kirby JA
    Br J Cancer; 2002 Oct; 87(9):1034-41. PubMed ID: 12434297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug evaluation: ADH-1, an N-cadherin antagonist targeting cancer vascularization.
    Kelland L
    Curr Opin Mol Ther; 2007 Feb; 9(1):86-91. PubMed ID: 17330406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone-releasing hormone antagonist inhibits the invasiveness of human endometrial cancer cells by down-regulating twist and N-cadherin expression.
    Wu HM; Huang HY; Schally AV; Chao A; Chou HH; Leung PC; Wang HS
    Oncotarget; 2017 Jan; 8(3):4410-4421. PubMed ID: 28032599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of KL-6/MUC1 in pancreatic cancer tissues and its potential involvement in tumor metastasis.
    Xu H; Inagaki Y; Seyama Y; Du G; Wang F; Kokudo N; Tang W
    Oncol Rep; 2011 Aug; 26(2):371-6. PubMed ID: 21617869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cadherins as novel targets for anti-cancer therapy.
    Blaschuk OW; Devemy E
    Eur J Pharmacol; 2009 Dec; 625(1-3):195-8. PubMed ID: 19836380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting N-cadherin increases vascular permeability and differentially activates AKT in melanoma.
    Turley RS; Tokuhisa Y; Toshimitsu H; Lidsky ME; Padussis JC; Fontanella A; Deng W; Augustine CK; Beasley GM; Davies MA; Dewhirst MW; Tyler DS
    Ann Surg; 2015 Feb; 261(2):368-77. PubMed ID: 24646553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plakoglobin Reduces the in vitro Growth, Migration and Invasion of Ovarian Cancer Cells Expressing N-Cadherin and Mutant p53.
    Alaee M; Danesh G; Pasdar M
    PLoS One; 2016; 11(5):e0154323. PubMed ID: 27144941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. lncRNA MIR503HG functioned as a tumor suppressor and inhibited cell proliferation, metastasis and epithelial-mesenchymal transition in bladder cancer.
    Qiu F; Zhang MR; Zhou Z; Pu JX; Zhao XJ
    J Cell Biochem; 2019 Jun; 120(6):10821-10829. PubMed ID: 30672010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased expression of MUC1 induces apoptosis and inhibits migration in pancreatic cancer PANC-1 cells via regulation of Slug pathway.
    Zhao P; Meng M; Xu B; Dong A; Ni G; Lu L
    Cancer Biomark; 2017 Dec; 20(4):469-476. PubMed ID: 28869438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triptonide potently suppresses pancreatic cancer cell-mediated vasculogenic mimicry by inhibiting expression of VE-cadherin and chemokine ligand 2 genes.
    Han H; Du L; Cao Z; Zhang B; Zhou Q
    Eur J Pharmacol; 2018 Jan; 818():593-603. PubMed ID: 29162433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.